For citations:
Kovalenko L.P., Povarnina P.Yu., Zhurikov R.V., Alekseeva S.V., Kolik L.G., Gudasheva T.A., Durnev A.D., Dorofeev V.I. Anticancer activity of tyrosine kinase TrkA receptors antagonist GK-1 in experiment on mice with mammary gland adenocarcinoma Ca755. Pharmacokinetics and Pharmacodynamics. 2024;(3):49-56. (In Russ.) https://doi.org/10.37489/2588-0519-2024-3-49-56. EDN: IAGKGA